Eli Lilly stock jumps 8% after Alzheimer’s treatment slows disease progression in major trial
May 03, 2023 at 07:16 AM EDT
After one year, nearly half of trial's participants showed no disease progression, says Lilly.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|